Creso Pharma Ltd
ASX:CPH

Watchlist Manager
Creso Pharma Ltd Logo
Creso Pharma Ltd
ASX:CPH
Watchlist
Price: 0.008 AUD Market Closed
Market Cap: 17.7m AUD

Creso Pharma Ltd
Cash from Operating Activities

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

Creso Pharma Ltd
Cash from Operating Activities Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Cash from Operating Activities CAGR 3Y CAGR 5Y CAGR 10Y
Creso Pharma Ltd
ASX:CPH
Cash from Operating Activities
-AU$17.3m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Mayne Pharma Group Ltd
ASX:MYX
Cash from Operating Activities
AU$17.5m
CAGR 3-Years
N/A
CAGR 5-Years
-29%
CAGR 10-Years
N/A
Neuren Pharmaceuticals Ltd
ASX:NEU
Cash from Operating Activities
AU$137.6m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Botanix Pharmaceuticals Ltd
ASX:BOT
Cash from Operating Activities
-AU$78.6m
CAGR 3-Years
-92%
CAGR 5-Years
-35%
CAGR 10-Years
-52%
C
Clarity Pharmaceuticals Ltd
ASX:CU6
Cash from Operating Activities
-AU$54.8m
CAGR 3-Years
-60%
CAGR 5-Years
-52%
CAGR 10-Years
N/A
Nyrada Inc
ASX:NYR
Cash from Operating Activities
-AU$5.1m
CAGR 3-Years
-20%
CAGR 5-Years
-3%
CAGR 10-Years
N/A
No Stocks Found

Creso Pharma Ltd
Glance View

Market Cap
17.7m AUD
Industry
Pharmaceuticals

Creso Pharma Ltd. develops, registers and commercializes pharmaceutical-grade cannabis and hemp-hemp-derived therapeutic, nutraceutical, and lifestyle products with wide patient and consumer reach for human and animal health. The firm is engaged in developing cannabis and hemp-derived therapeutic-grade nutraceuticals and medical cannabis products with a range of applications in both human and animal health. The Company, through its subsidiary is also engaged in cultivates and harvests cannabis plants and supplies dried cannabis plant retail products. The firm is operating medical facility in Windsor, Nova Scotia with 6 treatment rooms and a laboratory dedicated to performing psychedelic-assisted psychotherapy and clinical research.

CPH Intrinsic Value
Not Available

See Also

What is Creso Pharma Ltd's Cash from Operating Activities?
Cash from Operating Activities
-17.3m AUD

Based on the financial report for Dec 31, 2022, Creso Pharma Ltd's Cash from Operating Activities amounts to -17.3m AUD.

What is Creso Pharma Ltd's Cash from Operating Activities growth rate?
Cash from Operating Activities CAGR 1Y
23%

Over the last year, the Cash from Operating Activities growth was 23%.

Back to Top